Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
B-Lymphocytes | 19 | 2023 | 4665 | 2.320 |
Why?
|
Immunoglobulin Class Switching | 10 | 2017 | 291 | 1.950 |
Why?
|
Receptors, Antigen, B-Cell | 4 | 2018 | 548 | 1.610 |
Why?
|
Immunoglobulins | 5 | 2019 | 881 | 1.570 |
Why?
|
Immunoglobulin E | 6 | 2020 | 1463 | 1.530 |
Why?
|
Immunoglobulin Heavy Chains | 8 | 2023 | 659 | 1.370 |
Why?
|
Immunoglobulin G | 6 | 2023 | 4560 | 0.900 |
Why?
|
Antibody Affinity | 3 | 2021 | 254 | 0.790 |
Why?
|
Common Variable Immunodeficiency | 2 | 2019 | 93 | 0.740 |
Why?
|
Antibody Formation | 3 | 2023 | 1402 | 0.730 |
Why?
|
Symbiosis | 3 | 2018 | 287 | 0.730 |
Why?
|
Measles virus | 1 | 2019 | 68 | 0.710 |
Why?
|
Antibodies, Viral | 8 | 2022 | 3176 | 0.640 |
Why?
|
Mycoplasma Infections | 1 | 2018 | 118 | 0.620 |
Why?
|
Peanut Hypersensitivity | 1 | 2020 | 163 | 0.620 |
Why?
|
Measles | 1 | 2019 | 168 | 0.610 |
Why?
|
Autoimmunity | 2 | 2023 | 1349 | 0.600 |
Why?
|
Biological Therapy | 1 | 2018 | 138 | 0.570 |
Why?
|
Immunoglobulin M | 2 | 2021 | 1537 | 0.570 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2019 | 266 | 0.530 |
Why?
|
Germinal Center | 1 | 2017 | 377 | 0.510 |
Why?
|
Lymphocyte Activation | 4 | 2020 | 5524 | 0.490 |
Why?
|
Autoantibodies | 1 | 2023 | 2035 | 0.490 |
Why?
|
Intestinal Mucosa | 2 | 2016 | 3036 | 0.460 |
Why?
|
Tight Junctions | 1 | 2016 | 311 | 0.460 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2018 | 652 | 0.460 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1339 | 0.440 |
Why?
|
Vaccines | 1 | 2022 | 822 | 0.440 |
Why?
|
Immunoglobulin epsilon-Chains | 1 | 2011 | 16 | 0.420 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 4 | 2015 | 111 | 0.420 |
Why?
|
Immunoglobulin mu-Chains | 1 | 2011 | 62 | 0.410 |
Why?
|
Immunity, Humoral | 2 | 2020 | 598 | 0.410 |
Why?
|
Cell Lineage | 3 | 2019 | 2504 | 0.400 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 808 | 0.380 |
Why?
|
Recombination, Genetic | 3 | 2011 | 1586 | 0.370 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2022 | 4386 | 0.340 |
Why?
|
Food Hypersensitivity | 1 | 2016 | 622 | 0.330 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1540 | 0.320 |
Why?
|
Immune Evasion | 2 | 2021 | 360 | 0.310 |
Why?
|
Epitopes | 5 | 2022 | 2571 | 0.310 |
Why?
|
Antiphospholipid Syndrome | 1 | 2009 | 173 | 0.300 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3712 | 0.300 |
Why?
|
Bacteria | 1 | 2018 | 2114 | 0.290 |
Why?
|
Interferon-gamma | 3 | 2004 | 3206 | 0.280 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4803 | 0.280 |
Why?
|
Germ-Free Life | 2 | 2018 | 188 | 0.270 |
Why?
|
Macrophages | 4 | 2004 | 5655 | 0.260 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3597 | 0.260 |
Why?
|
Immunoglobulin A | 2 | 2021 | 992 | 0.260 |
Why?
|
Pluripotent Stem Cells | 1 | 2012 | 795 | 0.260 |
Why?
|
Clone Cells | 2 | 2019 | 1692 | 0.260 |
Why?
|
Animals | 30 | 2023 | 168757 | 0.260 |
Why?
|
Carrier Proteins | 4 | 2023 | 5021 | 0.240 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2004 | 38 | 0.240 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2003 | 595 | 0.240 |
Why?
|
DNA Breaks, Double-Stranded | 5 | 2013 | 594 | 0.230 |
Why?
|
Sarcoidosis | 1 | 2009 | 506 | 0.230 |
Why?
|
Epitope Mapping | 2 | 2023 | 311 | 0.230 |
Why?
|
Immune System | 2 | 2019 | 805 | 0.220 |
Why?
|
DNA-Binding Proteins | 9 | 2013 | 9648 | 0.210 |
Why?
|
Immunoglobulin Light Chains | 1 | 2023 | 277 | 0.210 |
Why?
|
Immunodominant Epitopes | 1 | 2023 | 267 | 0.210 |
Why?
|
Mice | 20 | 2023 | 81183 | 0.210 |
Why?
|
DNA Repair | 4 | 2012 | 2046 | 0.190 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2012 | 1736 | 0.190 |
Why?
|
Antigens | 2 | 2017 | 1466 | 0.190 |
Why?
|
Host-Pathogen Interactions | 2 | 2023 | 1477 | 0.190 |
Why?
|
Amino Acid Motifs | 1 | 2023 | 936 | 0.190 |
Why?
|
Antigens, Plant | 1 | 2020 | 86 | 0.180 |
Why?
|
Membrane Fusion | 1 | 2021 | 273 | 0.180 |
Why?
|
Interferon-Stimulated Gene Factor 3 | 3 | 2004 | 10 | 0.180 |
Why?
|
Humans | 39 | 2023 | 744343 | 0.180 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7181 | 0.180 |
Why?
|
Immunity, Cellular | 2 | 2023 | 1607 | 0.170 |
Why?
|
Antibodies, Neutralizing | 4 | 2022 | 1978 | 0.170 |
Why?
|
Antibody Diversity | 1 | 2019 | 74 | 0.170 |
Why?
|
Mutation | 5 | 2022 | 29786 | 0.170 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2021 | 279 | 0.170 |
Why?
|
Plateletpheresis | 1 | 2018 | 47 | 0.170 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2019 | 97 | 0.160 |
Why?
|
Mycoplasma hominis | 1 | 2018 | 9 | 0.160 |
Why?
|
Vaccines, DNA | 1 | 2020 | 305 | 0.160 |
Why?
|
Cysteine | 1 | 2023 | 874 | 0.160 |
Why?
|
Haptens | 1 | 2017 | 166 | 0.160 |
Why?
|
Sampling Studies | 1 | 2019 | 623 | 0.150 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2013 | 736 | 0.150 |
Why?
|
Immunoglobulin Variable Region | 1 | 2018 | 421 | 0.140 |
Why?
|
Granuloma | 1 | 2019 | 319 | 0.140 |
Why?
|
Blood Donors | 1 | 2018 | 355 | 0.140 |
Why?
|
Molecular Conformation | 1 | 2017 | 563 | 0.140 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2009 | 2104 | 0.140 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2023 | 1366 | 0.140 |
Why?
|
Lymphopenia | 1 | 2018 | 285 | 0.140 |
Why?
|
Central Nervous System | 1 | 2004 | 1357 | 0.140 |
Why?
|
Antigens, CD | 2 | 2003 | 4026 | 0.140 |
Why?
|
Precursor Cells, B-Lymphoid | 2 | 2013 | 98 | 0.130 |
Why?
|
Microglia | 1 | 2004 | 1266 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 3870 | 0.130 |
Why?
|
Transcription Factors | 3 | 2004 | 12208 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2003 | 4420 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.130 |
Why?
|
Peyer's Patches | 1 | 2015 | 121 | 0.130 |
Why?
|
Gene Conversion | 1 | 2014 | 71 | 0.120 |
Why?
|
Repressor Proteins | 2 | 2003 | 3023 | 0.120 |
Why?
|
Models, Molecular | 3 | 2021 | 5456 | 0.120 |
Why?
|
Immunity, Mucosal | 1 | 2018 | 490 | 0.120 |
Why?
|
Electricity | 1 | 2015 | 182 | 0.120 |
Why?
|
Autoantigens | 1 | 2019 | 892 | 0.120 |
Why?
|
Viral Vaccines | 1 | 2020 | 636 | 0.120 |
Why?
|
Antibodies | 1 | 2022 | 2460 | 0.120 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2018 | 547 | 0.120 |
Why?
|
Trypsin | 1 | 2014 | 511 | 0.120 |
Why?
|
Translocation, Genetic | 2 | 2010 | 1420 | 0.120 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1641 | 0.120 |
Why?
|
Spleen | 2 | 2018 | 2362 | 0.110 |
Why?
|
Weaning | 1 | 2013 | 105 | 0.110 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2015 | 214 | 0.110 |
Why?
|
DNA Ligases | 2 | 2010 | 80 | 0.110 |
Why?
|
Nervous System Diseases | 1 | 2004 | 1622 | 0.110 |
Why?
|
Cervix Uteri | 1 | 2017 | 590 | 0.110 |
Why?
|
Chickens | 1 | 2014 | 865 | 0.110 |
Why?
|
Virus Replication | 1 | 2021 | 2534 | 0.110 |
Why?
|
Telomere-Binding Proteins | 1 | 2013 | 116 | 0.110 |
Why?
|
Antigens, Nuclear | 2 | 2010 | 192 | 0.110 |
Why?
|
Pneumonectomy | 1 | 2019 | 1094 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3133 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 2 | 2003 | 264 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.100 |
Why?
|
Cattle | 1 | 2018 | 3922 | 0.100 |
Why?
|
Sheep | 1 | 2014 | 1437 | 0.100 |
Why?
|
Cytidine Deaminase | 2 | 2011 | 252 | 0.100 |
Why?
|
Intestine, Small | 1 | 2018 | 1241 | 0.100 |
Why?
|
Vagina | 1 | 2017 | 825 | 0.100 |
Why?
|
Desensitization, Immunologic | 1 | 2016 | 483 | 0.100 |
Why?
|
Cytokines | 2 | 2004 | 7322 | 0.100 |
Why?
|
RNA, Messenger | 2 | 2023 | 13033 | 0.090 |
Why?
|
Exoribonucleases | 1 | 2011 | 95 | 0.090 |
Why?
|
Cytological Techniques | 1 | 2012 | 219 | 0.090 |
Why?
|
Nanostructures | 1 | 2015 | 551 | 0.090 |
Why?
|
Immunoglobulin Switch Region | 1 | 2010 | 46 | 0.090 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10180 | 0.090 |
Why?
|
Cell Line | 5 | 2021 | 15997 | 0.090 |
Why?
|
Genetic Techniques | 1 | 2012 | 435 | 0.090 |
Why?
|
Immunosuppressive Agents | 1 | 2002 | 4149 | 0.090 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2009 | 62 | 0.090 |
Why?
|
Dermatitis, Atopic | 1 | 2016 | 654 | 0.080 |
Why?
|
Biosensing Techniques | 1 | 2015 | 668 | 0.080 |
Why?
|
Multigene Family | 1 | 2012 | 1102 | 0.080 |
Why?
|
Protein Conformation | 3 | 2021 | 4011 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15540 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 2540 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2021 | 2958 | 0.080 |
Why?
|
Cross Reactions | 2 | 2021 | 841 | 0.080 |
Why?
|
Hypersensitivity | 1 | 2017 | 1102 | 0.080 |
Why?
|
Genes, Immunoglobulin | 1 | 2009 | 291 | 0.080 |
Why?
|
Rabbits | 1 | 2014 | 4894 | 0.080 |
Why?
|
Blood Platelets | 1 | 2018 | 2508 | 0.080 |
Why?
|
Transcription, Genetic | 3 | 2015 | 7722 | 0.080 |
Why?
|
Cryoelectron Microscopy | 2 | 2021 | 571 | 0.080 |
Why?
|
Homeostasis | 2 | 2017 | 3340 | 0.080 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 21827 | 0.070 |
Why?
|
Multienzyme Complexes | 1 | 2011 | 686 | 0.070 |
Why?
|
Antigens, Viral | 2 | 2021 | 1035 | 0.070 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 884 | 0.070 |
Why?
|
Transfection | 3 | 2003 | 5892 | 0.070 |
Why?
|
Cell Separation | 1 | 2012 | 1751 | 0.070 |
Why?
|
Male | 10 | 2023 | 350118 | 0.070 |
Why?
|
Signal Transduction | 3 | 2004 | 23403 | 0.070 |
Why?
|
Protein Binding | 3 | 2023 | 9386 | 0.070 |
Why?
|
Child Development | 1 | 2017 | 2223 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2017 | 5974 | 0.070 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2513 | 0.070 |
Why?
|
Down-Regulation | 2 | 2003 | 3002 | 0.070 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11366 | 0.060 |
Why?
|
Swine | 1 | 2014 | 5917 | 0.060 |
Why?
|
TNF Receptor-Associated Death Domain Protein | 1 | 2004 | 5 | 0.060 |
Why?
|
Life Style | 1 | 2016 | 3835 | 0.060 |
Why?
|
Molsidomine | 1 | 2003 | 21 | 0.060 |
Why?
|
NF-kappa B | 2 | 2003 | 2499 | 0.060 |
Why?
|
Peroxynitrous Acid | 1 | 2003 | 41 | 0.060 |
Why?
|
Reactive Nitrogen Species | 1 | 2003 | 35 | 0.060 |
Why?
|
Genome | 1 | 2012 | 1808 | 0.060 |
Why?
|
Female | 10 | 2023 | 380194 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8388 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2021 | 9274 | 0.060 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2022 | 27 | 0.050 |
Why?
|
Skin | 1 | 2016 | 4364 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2004 | 443 | 0.050 |
Why?
|
CD40 Ligand | 1 | 2004 | 526 | 0.050 |
Why?
|
DNA Damage | 1 | 2012 | 2432 | 0.050 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2002 | 175 | 0.050 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2002 | 143 | 0.050 |
Why?
|
Viral Load | 2 | 2021 | 3299 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9438 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2003 | 1454 | 0.050 |
Why?
|
ABO Blood-Group System | 1 | 2023 | 367 | 0.050 |
Why?
|
Mesocricetus | 1 | 2021 | 252 | 0.050 |
Why?
|
Macrophage Activation | 1 | 2004 | 558 | 0.050 |
Why?
|
Galectins | 1 | 2023 | 268 | 0.050 |
Why?
|
RNA | 1 | 2011 | 2749 | 0.050 |
Why?
|
Neutralization Tests | 1 | 2022 | 758 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2849 | 0.050 |
Why?
|
Histones | 1 | 2010 | 2599 | 0.050 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9734 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2011 | 14557 | 0.040 |
Why?
|
Drug Synergism | 1 | 2003 | 1792 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3462 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 631 | 0.040 |
Why?
|
Cytoplasm | 1 | 2003 | 1539 | 0.040 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2021 | 474 | 0.040 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2023 | 880 | 0.040 |
Why?
|
Genes, myc | 2 | 2010 | 399 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2013 | 5853 | 0.040 |
Why?
|
RNA Precursors | 1 | 1999 | 208 | 0.040 |
Why?
|
Mutant Proteins | 1 | 2020 | 500 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2020 | 340 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2020 | 768 | 0.040 |
Why?
|
Protein Subunits | 1 | 2021 | 959 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2015 | 11483 | 0.040 |
Why?
|
Endoribonucleases | 1 | 1999 | 229 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39050 | 0.040 |
Why?
|
Nasal Mucosa | 1 | 2020 | 373 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2021 | 541 | 0.040 |
Why?
|
Protein Engineering | 1 | 2021 | 540 | 0.040 |
Why?
|
Cricetinae | 1 | 2021 | 2472 | 0.040 |
Why?
|
Prevotella | 1 | 2017 | 79 | 0.040 |
Why?
|
Bacteria, Anaerobic | 1 | 2017 | 68 | 0.040 |
Why?
|
Middle Aged | 4 | 2023 | 213383 | 0.040 |
Why?
|
Protein Multimerization | 1 | 2021 | 970 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1791 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2003 | 2077 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20129 | 0.030 |
Why?
|
Embryo, Mammalian | 2 | 2013 | 1701 | 0.030 |
Why?
|
Platelet Count | 1 | 2018 | 781 | 0.030 |
Why?
|
Lactobacillus | 1 | 2017 | 189 | 0.030 |
Why?
|
Ligands | 1 | 2023 | 3282 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2004 | 12072 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 63114 | 0.030 |
Why?
|
RNA Interference | 1 | 2004 | 2889 | 0.030 |
Why?
|
Binding Sites | 1 | 2004 | 6114 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2020 | 1000 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2003 | 1889 | 0.030 |
Why?
|
Limit of Detection | 1 | 2015 | 265 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 944 | 0.030 |
Why?
|
Comorbidity | 1 | 2009 | 10388 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 2015 | 683 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2020 | 2375 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2020 | 1348 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2003 | 2948 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13695 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2023 | 19229 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4204 | 0.030 |
Why?
|
South Africa | 1 | 2017 | 1731 | 0.020 |
Why?
|
Aged | 3 | 2018 | 163280 | 0.020 |
Why?
|
Alleles | 1 | 2022 | 6933 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2002 | 5867 | 0.020 |
Why?
|
Peptides | 1 | 2023 | 4409 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2015 | 2557 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5078 | 0.020 |
Why?
|
HIV Infections | 1 | 2017 | 16718 | 0.020 |
Why?
|
Chromosomes, Mammalian | 1 | 2010 | 151 | 0.020 |
Why?
|
Adult | 3 | 2019 | 214055 | 0.020 |
Why?
|
Microfluidics | 1 | 2015 | 662 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19905 | 0.020 |
Why?
|
Weight Loss | 1 | 2021 | 2622 | 0.020 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2009 | 87 | 0.020 |
Why?
|
Blotting, Southern | 1 | 2010 | 803 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2010 | 898 | 0.020 |
Why?
|
Receptors, Complement 3d | 1 | 2009 | 118 | 0.020 |
Why?
|
Interphase | 1 | 2009 | 226 | 0.020 |
Why?
|
Environment | 1 | 2015 | 1124 | 0.020 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2009 | 173 | 0.020 |
Why?
|
Genomic Instability | 1 | 2013 | 695 | 0.020 |
Why?
|
Temperature | 1 | 2015 | 2206 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2017 | 2258 | 0.020 |
Why?
|
Glioblastoma | 1 | 2003 | 3481 | 0.020 |
Why?
|
Vaccination | 1 | 2020 | 3278 | 0.020 |
Why?
|
Proteins | 1 | 2002 | 6103 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3582 | 0.020 |
Why?
|
Integrases | 1 | 2009 | 533 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2013 | 1149 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13989 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 2892 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14722 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 16689 | 0.010 |
Why?
|
Base Sequence | 2 | 2010 | 12797 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2649 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2017 | 4234 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10262 | 0.010 |
Why?
|
Fibroblasts | 1 | 2013 | 4161 | 0.010 |
Why?
|
Health Care Costs | 1 | 2016 | 3209 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2010 | 18111 | 0.010 |
Why?
|
Doxycycline | 1 | 2003 | 326 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18029 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2421 | 0.010 |
Why?
|
Chromatin | 1 | 2010 | 2934 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40075 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29063 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 25043 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 25625 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2003 | 1783 | 0.010 |
Why?
|
Nucleotides | 1 | 1999 | 464 | 0.010 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 1999 | 436 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 40561 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1999 | 3701 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 56430 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 72290 | 0.010 |
Why?
|
Neoplasms | 1 | 2016 | 21683 | 0.000 |
Why?
|